Lenka S. Mrazova

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Journal: Journal of molecular and cellular cardiology plus

Published: April 23, 2026

Severe Prenatal Presentation of Adenylosuccinate Lyase Deficiency Caused by a Synonymous ADSL Variant Inducing Aberrant Splicing.

Journal: Prenatal diagnosis

Published: November 28, 2025

Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

Journal: PloS one

Published: January 30, 2025

Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

Journal: PloS one

Published: March 10, 2023

A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis.

Journal: Kidney international

Published: December 11, 2020

Serum Bilirubin in the Czech Population　- Relationship to the Risk of Myocardial Infarction in Males.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: August 28, 2020

3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients.

Journal: Molecular genetics and metabolism

Published: April 27, 2017

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

Journal: Pharmacogenomics

Published: June 15, 2016

HGSNAT has a TATA-less promoter with multiple starts of transcription.

Journal: Gene

Published: May 09, 2016

Two novel mutations in mitochondrial acetoacetyl-CoA thiolase deficiency.

Journal: Journal of inherited metabolic disease

Published: May 26, 2004

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Severe Prenatal Presentation of Adenylosuccinate Lyase Deficiency Caused by a Synonymous ADSL Variant Inducing Aberrant Splicing.

Severe Prenatal Presentation of Adenylosuccinate Lyase Deficiency Caused by a Synonymous ADSL Variant Inducing Aberrant Splicing.

Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis.

A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis.

Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males.

Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males.

3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients.

3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients.

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

HGSNAT has a TATA-less promoter with multiple starts of transcription.

HGSNAT has a TATA-less promoter with multiple starts of transcription.

Two novel mutations in mitochondrial acetoacetyl-CoA thiolase deficiency.

Two novel mutations in mitochondrial acetoacetyl-CoA thiolase deficiency.

Serum Bilirubin in the Czech Population　- Relationship to the Risk of Myocardial Infarction in Males.

Serum Bilirubin in the Czech Population　- Relationship to the Risk of Myocardial Infarction in Males.